Frontlight ResearchEarly access
Trial site
Kuala Selangor
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia4 trials
- Immune thrombocytopenia (ITP)2 trials
- Myeloproliferative neoplasms2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 36 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals8 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
Closed trials
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026